Level of Some Adipokines in Obese Type 2 Diabetic
Egyptian Patients with Coronary Artery Stenosis
Volume 1 - Issue 3
Rania Farag A El Telbany*
-
Author Information
Open or Close
- Biochemistry Department, Modern University for Technology and Information, Egypt
*Corresponding author:
Rania Farag A El Telbany, Biochemistry Department, Faculty of Pharmacy, Modern University for Technology
and Information, Cairo, Egypt
Received: January 16, 2018; Published: February 05, 2018
DOI: 10.32474/AOICS.2018.01.000111
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Cardiovascular diseases (CVD) are the leading global cause of
death accounting for 17.5 million deaths per year, a number that is
expected to grow to more than 23.6 million by 2030. Cardiovascular
diseases result mainly from atherosclerosis which involves a
chronic and progressive inflammatory response of the vessel
wall to injuries promoted by risk factors such as hypertension,
dyslipidemia, diabetes and others. Type 2 diabetes mellitus
(T2DM) is usually proceeded with a state of insulin resistance
or insufficient insulin signal pathways that plays a crucial role in
the pathogenesis of the disease and its associated complication.
Obesity is a chronic serious and growing problem of excessive body
fat which has been linked with dyslipidaemia, CVD and diabetes.
Mini Review|
Introduction|
Results and Discussion|
Experimental Section|
References|